A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

Completed · Phase 2

Conditions studied: Diabetic Foot Ulcers

In brief

The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).

Key facts

Study ID

NCT01070433

Run by

Skingenix, Inc.

People needed

75

Starts

2012-09-01

Expected to finish

2013-12-01

Last updated by the study team

2025-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female ≥18 years of age
• Able and willing to provide informed consent
• Able and willing to comply with protocol visits and procedures
• Target ulcer duration of ≥4 weeks

You may not qualify if…

• Ulcer of a non-diabetic pathophysiology
• Known or suspected allergies to any of the components of MEBO
• Malignancy on target ulcer foot
• Non-compliance in the screening or run-in period

Where it is running

• HOPE Research Institute — Phoenix, Arizona, United States
• Center for Clinical Research, Inc. — Castro Valley, California, United States
• ILD Consulting, Inc. — Encinitas, California, United States
• Sacramento Foot and Ankle Center — Fair Oaks, California, United States
• Valley Vascular Surgery Associates — Fresno, California, United States
• Foot and Ankle Clinic — Los Angeles, California, United States
• Advanced Foot and Ankle Center — Las Vegas, Nevada, United States
• Complete Family Foot Care — McAllen, Texas, United States
• Endeavor Clinical Trials, San Antonio Podiatry Associates — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.